What is the ticker symbol for Twist Bioscience?

Twist Bioscience trades under the ticker TWST on NASDAQ.

What sector does Twist Bioscience operate in?

Twist Bioscience is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze TWST in a portfolio?

PortView shows TWST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Twist Bioscience (TWST) Stock Analysis

NASDAQHealthcareMedical - Diagnostics & Research

$127.85-3.19%

1-year price historyRange $24.16 – $153.10

52-week range$127.85

$23.30$155.44

What Twist Bioscience does

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.

Key metrics

Market cap

$7.96B

P/E (TTM)

-57.59

EPS (TTM)

$-2.22

Beta

2.16

Dividend yield

0.00%

Revenue / share

$6.92

50-day avg

$108.69

200-day avg

$63.25

52-week high

$155.44

52-week low

$23.30

CEO

Emily Marine Leproust

ETFs linked to TWST

Broad-market and Healthcare sector ETFs an investor holding Twist Bioscience is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TWST fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TWST in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Twist Bioscience?: Twist Bioscience trades under the ticker TWST on NASDAQ.
Which exchange is TWST listed on?: TWST is listed on NASDAQ.
What sector does Twist Bioscience operate in?: Twist Bioscience is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
How can PortView help analyze TWST in a portfolio?: PortView shows TWST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.